NEW YORK (GenomeWeb News) – Oracle announced earlier this week the creation of the Oracle Health Sciences Institute to accelerate IT innovation directed at personalized medicine.
The creation of the institute was done in partnership with Sun Labs, which Oracle acquired last year. Oracle will work with academic centers with a focus on research areas "fundamental to the R&D and healthcare delivery challenges facing health sciences organizations today," the company said in a statement.
Oracle's current research priorities include genomic, genetic, and phenotypic data analysis, data mining in support of clinical trials; artificial intelligence and semantic technology; predictive algorithms, and other technologies "to advance patient safety and provide advanced decision support at the point of care."